Navigation Links
NightHawk Radiology Holdings, Inc. Announces Preliminary 2007 Results
Date:1/28/2008

COEUR D'ALENE, Idaho, Jan. 28 /PRNewswire-FirstCall/ -- NightHawk Radiology Holdings, Inc. (Nasdaq: NHWK), the leading provider of radiology solutions to radiology groups across the United States, today announced its preliminary, unaudited financial results for the year ended December 31, 2007. Results are subject to completion of the company's customary closing and review procedures.

Preliminary 2007 Results

The company expects to report 2007 revenue in the range of $151 to $152 million, compared to $92 million in 2006, and 2007 adjusted earnings per diluted share in the range of $0.90 to $0.91, compared to adjusted earnings per diluted share of $0.70 in 2006. The company's calculation of adjusted earnings per diluted share excludes certain non-cash charges, including stock compensation, IBNR reserves and the amortization of intangibles associated with acquisitions. Also excluded from the calculation of 2007 adjusted earnings per diluted share is a one-time charge of approximately $0.5 million related to the settlement of an acquisition-related legal dispute.

The company's 2007 results were impacted by slightly lower fourth quarter volumes due to greater than expected seasonality, and a delay in transitioning the former Radlinx physician contracts to the company's compensation model.

Conference Call & Web Cast

The fourth quarter and full-year 2007 conference call will be held on Wednesday, February 13, 2008 at 8:30 a.m. (ET). A live webcast of the conference call, as well as a replay, will be available online on the company's corporate website at http://www.nighthawkrad.net. Participants can also access the call by dialing 800-240-4186 (within the
'/>"/>

SOURCE NightHawk Radiology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008
2. NightHawk Radiology: One Source, One Solution
3. NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007
4. NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
5. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
6. Foundation Radiology Group Formalizes Strategic Partnership with Emageon to Provide Advanced Imaging Software to Facilitate Industry-Leading Turnaround and Patient Care Response Times
7. Radiology Support Devices Introduces New Breathing Phantom System
8. Merge Healthcare Teleradiology Division Receives Accreditation From Joint Commission
9. Eclipsys Sunrise Radiology Helps Trinitas Hospital Achieve Financial Outcome Improvements
10. AMICAS Solutions Closing the Loop in Radiology Communications
11. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...local dance students will dance to raise money for...S, Jan. 8 , , , WHO: ...how off their talent in the 3rd annual Dance, ...nce Arts Centre. The, event will ..., Participants raise money throug...
(Date:1/8/2009)..., Md., Jan. 8 /PRNewswire-Asia/ -- Chindex Interna...mpany"), a leading independent American,provider ... People,s Republic,of China, today announced that...na Conference, to be held in Shanghai on January 1...Conference will be held at the Pudong Shangri-,La...
(Date:1/8/2009)...romoted to Principal. Christine Siu and Jason Bro...POLIS, SAN FRANCISCO and STAMFORD, Conn., Jan. 8 /...health care venture capital firm that invests in l...y announced the promotion of three members of its ...Principal. Christine Siu and Jason Brown have bee...
(Date:1/8/2009)... Tenn., Jan. 8 St. Jude Children,s...p announced that FedExCup Runner-Up,Camilo Villeg...Jude with a,pledge to match Singh,s donation of $... 2009 PGA TOUR. Eagles for St. Jude is a powerful...ion Vijay Singh and rising LPGA star Morgan,Press...
Breaking Medicine News(10 mins):Health News:Dance With Courage to Benefit Camp Courage 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...gers drawn on many issues, however one issue that ...ent in India of 70 poor Pakistani children later t...s likely to pave path towards many more similar ge... the two countries that politician on both sides o...
... stents that release the medication paclitaxel red...nths following angioplasty for patients with compl...e in the September 14 issue of JAMA. Drug-eluting ... of atherosclerotic coronary artery disease, accor...
...n Uttar Pradesh crossed 800 Saturday. But the admi... believed to be at the root of the virtual epidemi...orse as the animal is known to be the biggest host...carried across to human beings by mosquitoes. Utt...
... the heart from the use of stem cells. French rese...o repair heart damage in sheep, reporting their re...ncet. Heart failure is a major cause of death in d... when cells within the heart are damaged after a h...
Other Medicine News:Health News:Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childr 2Health News:Stents That Release Medication To Check Artery Narrowing 2Health News:Pigs Population A Major Threat To Encephalitis Ravaged UP 2
(Date:1/5/2009)...e/ -- Cylene Pharmaceuticals announced today that ...ral CK2 protein kinase inhibitor, CX-4945, in pati...se, or multiple myeloma. The primary endpoints of ...f safety, tolerance and PK properties of CX-4945 a...als. In addition, multiple mechanism-related pharm...
(Date:12/30/2008)...ire-USNewswire/ -- The Coalition for 21st Century ...ed by Genentech, Inc. on December 5, 2008, seeking...diagnostic tests to physicians and patients. The ...would harm patient care and rests on flawed scient...ssion is to encourage the research, development, a...
(Date:12/27/2008)...-year silence, offers to ease cloning costs for Cl...S, Dec. 27 Six years to...oned child, Dr. Brigitte Boisselier, head of the c...d other babies cloned by her company are growing u...eir families, privacy. , , "We,ve helped almost...
(Date:12/17/2008)...wswire/ -- PEAK Surgical, Inc., a medical,device ... system based on a,proprietary technology, announ...ion (FDA) has granted the company 510(k) clearance... and coagulation of soft tissue during,plastic an...cologic,orthopedic, arthroscopic, spinal and neu...
Breaking Medicine Technology:Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4'We're Ready to Prove It!' 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4Breckenridge Pharmaceutical Enters Agreement With Helm AG 28Hamburg Germany 29 to Develop Additional ANDA Project 15702 1CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 1CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 2CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 3mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 1mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 2mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 3mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 4mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 5Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 1Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 2Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 3Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 4Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 5Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 6
...SS WIRE)--Mar 26, 2007 - A study comparing,the for...lazine,(HYD) used in V-HeFT I and V-HeFT II, and B... in the African American Heart Failure,Trial (A-He...ence,in the formulations used may explain why V-He...n decreasing mortality. Using,identical amounts of...
...already being treated with maximally,tolerated lip...ctions in LDL-C with similar reductions in other a...12, NEW ORLEANS, and CARLSBAD, Calif., March 26, 2..., Inc. announced,results from its ongoing Phase 2 ...ozygous familial hypercholesterolemia (HoFH),pres...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: